Industry Experts

Christopher Dupont graduated from the University of Pennsylvania with a PhD in Cell and Molecular Biology. He has studied immune responses in various contexts since 2007, focusing on oncology since 2016. During this time, he has worked with various modalities including vaccines, checkpoint inhibitors, oncolytic viruses, and cell therapies. His is interested in clinical biomarkers, and utilizing patient samples to interrogate mechanisms of therapeutic action and cancer resistance. He is currently an Associate Director of Translational Sciences at Adaptimmune.